Therapeutic monitoring of serum concentrations of acyclovir and its metabolite 9-(carboxymethoxymethyl) guanine in routine clinical practice
Open Access
- 10 October 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113852
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (MH CZ – DRO-FNOs/2019)
This publication has 35 references indexed in Scilit:
- Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal FunctionAntimicrobial Agents and Chemotherapy, 2010
- Death delusionBMJ, 2007
- Acyclovir‐induced neuropsychosis successfully recovered after immediate hemodialysis in an end‐stage renal disease patientInternational Journal of Dermatology, 2007
- The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatmentJournal of Antimicrobial Chemotherapy, 2006
- A double-blind, randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpesJournal of Antimicrobial Chemotherapy, 1999
- Valaciclovir for the Suppression of Recurrent Genital Herpes Simplex Virus Infection: A Large‐Scale Dose Range‐Finding StudyThe Journal of Infectious Diseases, 1998
- AciclovirDrugs, 1994
- Acyclovir concentrations in serum and cerebrospinal fluid at steady stateJournal of Antimicrobial Chemotherapy, 1989
- Excessive Serum Concentrations of Acyclovir and NeurotoxicityThe Journal of Infectious Diseases, 1988
- Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: Correlation of viral susceptibilities and plasma levels with response to therapyDiagnostic Microbiology and Infectious Disease, 1987